What have we learnt from past failures in Alzheimer's disease drug discovery?

Ramón Cacabelos

doi:10.1080/17460441.2022.2033724

What have we learnt from past failures in Alzheimer's disease drug discovery?

Expert Opin Drug Discov. 2022 Apr;17(4):309-323. doi: 10.1080/17460441.2022.2033724. Epub 2022 Feb 6.

Author

Ramón Cacabelos¹

Affiliation

¹ International Center of Neuroscience and Genomic Medicine, EuroEspes Biomedical Research Center, Corunna, Spain.

PMID: 35129021
DOI: 10.1080/17460441.2022.2033724

No abstract available

Keywords: Alzheimer’s disease; biomarkers; drug development; epigenetics; immunotherapy; pathogenic genomics; pharmacogenetics; pharmacological treatment.

Publication types

Editorial

MeSH terms

Alzheimer Disease* / drug therapy
Drug Discovery
Humans
Pharmacogenetics